Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of FCU-08 in acute kidney injury requiring continuous blood purification
jRCT2080222745Phase 2Completed
- Sponsor
- Fuso Pharmaceutical Industries
- Start
- Feb 2015
- Countries
- 1
01
Overview
Phase 2, open-label trial of FCU-08 in acute kidney failure (AKF) (2 arms), sponsored by Fuso Pharmaceutical Industries. Started Feb 2015; status: completed.
02
Drugs
FCU-08
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on jRCT2080222745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222745.